Angiotensin II deteriorates endothelial progenitor cells: Good intentions with bad consequences

Hypertension

Volumn 58, Issue 3, 2011, Pages 356-358

  Roks, Anton J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE;

ANGIOGENESIS; ANTIHYPERTENSIVE THERAPY; APOPTOSIS; ATHEROGENESIS; BLOOD PRESSURE; BONE MARROW CELL; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVATION; INHIBITION KINETICS; MONONUCLEAR CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; ANIMALS; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; RECEPTOR, ANGIOTENSIN, TYPE 1; STEM CELLS;

EID: 80051943102     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.170506     Document Type: Note

References (9)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-967. (Pubitemid 27087709)
2. Roks AJ, Rodgers K, Walther T. Effects of the renin angiotensin system on vasculogenesis-related progenitor cells. Curr Opin Pharmacol. 2011;11: 162-174.
3. Kim H, Cho HJ, Kim SW, Liu B, Choi YJ, Lee J, Sohn YD, Lee MY, Houge MA, Yoon YS. CD31Acells represent highly angiogenic and vasculogenic cells in bone marrow: novel role of nonendothelial CD31Acells in neovascularization and their therapeutic effects on ischemic vascular disease. Circ Res. 2010;107:602-614.
4. Endtmann C, Ebrahimian T, Czech T, Arfa O, Laufs U, Fritz M, Wassmann K, Werner N, Petoumenos V, Nickenig G, Wassmann S. Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration. Hypertension. 2011;58:394-403.
5. Kobayashi K, Imanishi T, Akasaka T. Endothelial progenitor cell differentiation and senescence in an angiotensin II-infusion rat model. Hypertens Res. 2006;29:449-455. (Pubitemid 44102813)
6. Imanishi T, Hano T, Nishio I. Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J Hypertens. 2005;23:97-104. (Pubitemid 40128986)
7. Yin T, Ma X, Zhao L, Cheng K, Wang H. Angiotensin II promotes NO production, inhibits apoptosis and enhances adhesion potential of bone marrow-derived endothelial progenitor cells. Cell Res. 2008;18:792-799. (Pubitemid 351948226)
8. Imanishi T, Hano T, Nishio I. Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells. Hypertens Res. 2004;27:101-108. (Pubitemid 38331920)
9. Silva J, Pastorello M, Arzola J, Zavala LE, De Jesus S, Varela M, Matos MG, del Rosario Garrido M, Israel A. AT1 receptor and NAD(P)H oxidase mediate angiotensin II-stimulated antioxidant enzymes and mitogen-activated protein kinase activity in the rat hypothalamus. J Renin Angiotensin Aldosterone Syst. 2010;11:234-242.